People with a family history of cancerous brain tumors appear to be at higher risk of developing the same kind of tumors compared to people with no such family history, according to a study published in the September 23, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology. For the study, researchers looked at the medical records of 1,401 people from Utah with primary brain tumors. Read more ...
EXACT Sciences Corporation (NASDAQ: EXAS) announced the publication in the American Journal of Gastroenterology the results of a multi-center study of EXACT's Version 2 technology for stool-based DNA screening for colorectal cancer. The Company previously disclosed this study's acceptance for publication and its top line performance for colorectal cancer detection. The study, conducted by Steven H. Itzkowitz, M. Read more ...
Cancer patients with tumors that have spread to the brain (brain metastases) who undergo stereotactic radiosurgery (SRS) and whole brain radiation have more than double the risk of developing learning and memory problems, compared to those who only have stereotactic radiosurgery, according to a randomized study presented at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston. Read more ...
GE Global Research, the technology development arm for the General Electric Company (NYSE: GE), announced a two-year cooperative research and development agreement with the National Cancer Institute (NCI) to accelerate the development of cutting-edge nanoparticle based imaging agents that have the potential to revolutionize the diagnosis and treatment of cancer and heart disease. Read more ...
AVEO Pharmaceuticals, Inc., announced that it has initiated a Phase 1 clinical trial to evaluate the safety, tolerability and recommended dose of SCH900105 (AV-299), its novel, highly potent antibody to hepatocyte growth factor (HGF), administered intravenously in patients with relapsed or refractory solid tumors or lymphoma. SCH900105 (AV-299) is being developed in collaboration with Schering-Plough (NYSE: SGP). Read more ...
A new analysis indicates an association between a gene involved in vitamin D metabolism and skin cancer. Published in the November 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that individuals with certain variants in a vitamin D-related gene, called BsmI, may be at an increased risk of developing melanoma. Read more ...
MSNBC.com on Thursday examined an experimental procedure that aims to preserve the fertility of girls and young women undergoing medical treatments for cancer and other conditions that could cause them to become sterile. The procedure, featured on NBC's " Read more ...
Tuesday, September 23, 2008
Medicare HMO Costs May Prevent Cancer Patients From Enrolling In Clinical Trials, UPCI Study Finds
Newly diagnosed cancer patients who are enrolled in Medicare's Health Maintenance Organization (HMO) plans may be unlikely to participate in clinical trials because of prohibitive costs, according to a study by the University of Pittsburgh Cancer Institute (UPCI). Under these HMO plans, covering people age 65 and older, patients are required to pay both a deductible and 20 percent of the treatment cost. Complete news at...
A Wistar Institute researcher's novel approach to understanding genetic causes of human disease has earned him an NIH Director's New Innovator Award and grant from the National Institutes of Health. Ken-ichi Noma, Ph.D., an assistant professor in Wistar's Gene Expression and Regulation Program, is working to develop a new method of mapping the three-dimensional structure of the human genome. Complete news at...
The use of a short one week course of radiation before surgery for rectal cancer leads to a reduced risk of recurrence but with some impairment in quality of life for sexual and bowel function, according to an international study presented September 22, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston. The primary treatment for rectal cancer is surgery. Complete news at...
Genmab A/S (OMX: GEN) announced it has completed recruitment of 56 previously untreated follicular non-Hodgkin's lymphoma (NHL) patients in the Phase II study of ofatumumab (HuMax-CD20(R)) in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP). "We are happy to finish enrolment in this first study with ofatumumab in front line follicular NHL patients," said Lisa N. Drakeman, Ph.D., Chief Executive Officer at Genmab. Complete news at...
Quality assurance programs like the one at the Quality Assurance Review Center (QARC) in Worcester, Mass., strengthen the quality of clinical trials, including cooperative groups conducting National Cancer Institute-supported clinical trials, thereby improving the standard of care in cancer patients, according to a study presented at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston. Complete news at...
Trius Therapeutics, Inc. announced the initiation of Phase 2 testing of the oral form of its second-generation oxazolidinone antibacterial drug TR- 701. The multicenter trial will test the efficacy, safety and tolerability of once- daily doses of 200, 300 and 400 milligrams of TR-701 in complicated skin and skin structure infections (cSSSI) for five to seven days of treatment. Complete news at...
Cancer patients who receive stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) for the treatment of metastatic brain tumors have more than twice the risk of developing learning and memory problems than those treated with SRS alone, according to new research from The University of Texas M. D. Anderson Cancer Center. Complete news at...
A Wistar Institute researcher's novel approach to understanding genetic causes of human disease has earned him an NIH Director's New Innovator Award and grant from the National Institutes of Health. Ken-ichi Noma, Ph.D., an assistant professor in Wistar's Gene Expression and Regulation Program, is working to develop a new method of mapping the three-dimensional structure of the human genome. Complete news at...
The use of a short one week course of radiation before surgery for rectal cancer leads to a reduced risk of recurrence but with some impairment in quality of life for sexual and bowel function, according to an international study presented September 22, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston. The primary treatment for rectal cancer is surgery. Complete news at...
Genmab A/S (OMX: GEN) announced it has completed recruitment of 56 previously untreated follicular non-Hodgkin's lymphoma (NHL) patients in the Phase II study of ofatumumab (HuMax-CD20(R)) in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP). "We are happy to finish enrolment in this first study with ofatumumab in front line follicular NHL patients," said Lisa N. Drakeman, Ph.D., Chief Executive Officer at Genmab. Complete news at...
Quality assurance programs like the one at the Quality Assurance Review Center (QARC) in Worcester, Mass., strengthen the quality of clinical trials, including cooperative groups conducting National Cancer Institute-supported clinical trials, thereby improving the standard of care in cancer patients, according to a study presented at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston. Complete news at...
Trius Therapeutics, Inc. announced the initiation of Phase 2 testing of the oral form of its second-generation oxazolidinone antibacterial drug TR- 701. The multicenter trial will test the efficacy, safety and tolerability of once- daily doses of 200, 300 and 400 milligrams of TR-701 in complicated skin and skin structure infections (cSSSI) for five to seven days of treatment. Complete news at...
The Centre for Health Protection (CHP) of the Hong Kong Department of Health followed up a human case of myiasis involving an 84-year-old man and urged people to take measures to guard against the disease caused by fly maggots.
The patient, living in Kwun Tong, attended the Accident and Emergency Department of United Christian Hospital for right thigh pain on September 11. Maggots were found from a wound over his right ankle. He is now hospitalized in stable condition.
CHP's investigations revealed that he had no record of recent travel history.
Complete news at...Cancer patients who receive stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) for the treatment of metastatic brain tumors have more than twice the risk of developing learning and memory problems than those treated with SRS alone, according to new research from The University of Texas M. D. Anderson Cancer Center. Complete news at...
Angular Chelitis Treatment
An actual, factual Angular Chelitis treatment which works efficiently to eliminate it in its entirety seems to be quite an elusive thing to find. Reports on the effects of hydro cortisone products seem to show quite a considerably low success rate, and even antibiotics don't seem to be of much help. This of course, is due to the resilience of bacteria (in this case, fungal bacteria), which is generally the same reason that there exists no cure for the common cold - you simply cannot completely eradicate fungal bacteria in this manner. The rate at which they evolve, and their amazing adaptability to whatever we can throw at them, just makes the method of using these types of medications and creams as an Angular Chelitis treatment a wasted effort.
Subscribe to:
Posts (Atom)
